Pérez Blanco F J, Manzanares L, Moreno G, Cabello M J
Departamento de Medicina Interna, Hospital Universitario San Cecilio, Granada.
An Med Interna. 1996 Apr;13(4):193-7.
Diabetic nephropathy is the third cause of renal failure after pyelonephritis and glomerulonephritis. Lately, many efforts have been made for the early identification (on the silent stage) of patients with a high risk of developing this disease. On these initial stages, therapeutic attitude has changed very much, emphasizing nowadays the importance of glucose levels control, avoiding maintained conditions of hyperglycemia and maintaining blood pressure within the limits, by using the therapeutic store available, basically calcium antagonists and angiotensin-converting enzyme inhibitors.
糖尿病肾病是继肾盂肾炎和肾小球肾炎之后导致肾衰竭的第三个原因。最近,人们为早期识别(在无症状阶段)患有这种疾病高风险的患者付出了很多努力。在这些初始阶段,治疗态度发生了很大变化,如今强调血糖水平控制的重要性,通过使用现有的治疗药物,主要是钙拮抗剂和血管紧张素转换酶抑制剂,避免持续的高血糖状态并将血压维持在正常范围内。